Blosozumab
布索珠单抗
Report date: 2025/06/24 16:51:51
Base Information
Drug NameBlosozumab
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[6]
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesEli Lilly And Company
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesTranscenta Holding LtdHJB (Hangzhou) Co Ltd
Inactive CompaniesEli Lilly And Company
Active Indications
Inactive Indications